leader diabet digit health
manag growth look
price initi equal-weight
livongo digit health solut pois gain share
larg under-penetrated market first mover advantag
shift larger employ group support robust revenu
growth profil next year price target impli
upsid current level catalyst earn
livongo well posit gain share billion market
penetr livongo platform enhanc exist diabet care continuum
use technolog data scienc behavior insight help peopl type
diabet better manag diseas livongo offer help improv patient
adher lead better outcom lower cost first mover advantag
posit compani well benefit greenfield opportun channel
partnership express script strengthen
compani go-to-market strategi forecast assum livongo would
manag address diabet opportun leav ampl
room growth livongo also leverag exist platform expand
adjac hypertens market offer launch
forecast top-line compound-annual-growth-rate next three year livongo continu
gain traction larg employ group see livongo move upmarket
contract jumbo employ serv employe popul
meaning opportun compani revenu growth
target respect assum new client add
respect build compani exist client base
compani ad client time growth fuel
expans new payor market commerci risk medicar advantag
cross sell new offer notabl hypertens exist
custom upsel weight manag behavior health offer also
longer term margin expans opportun acceler pace new
member add product mix would like cap margin next year
see path bp margin expans long-term
benefit fix cost leverag glucomet devic
fulli expens mix shift
 distribut unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
price target livongo subscription-bas recur revenu model high
sticki client strong secular growth driver industri
first-mov advantag larg under-penetrated market provid
compani long runway growth said stock sinc
ipo versu market comp group
time period believ market alreadi price growth
potenti initi equal-weight arriv
base case price target appli ev/revenu multipl base case
sale estim million multipl in-lin averag
multipl high-growth saa compani high-growth healthcar compani
bull case valuat bear case
risk move upmarket larger employ could take longer
forecast may requir increment invest revenu
gener five channel partner one discontinu relat
livongo could materi impact sale growth healthplan
could develop offer reduc
larg under-penetrated support strong top-line growth prospect
larg under-penetrated support strong top-line growth prospect
livongo market leader diabet
pt impli base case revenu estim
million multipl in-lin averag ev/rev
multipl high-growth saa healthcar compani grow
top-line per year gross margin low rang
ev multipl appli bull case enu estim
mn revenu growth driven acceler rate
new client add particularli within commerci aso diabet market
well lower monthli member churn higher client add lead faster
member add success cross-sel hypertens product
ev multipl appli base case enu estim
mn revenu growth driven
expand membership within exist client sign new commerci
aso client expans new payor market cross-sel
ev multipl appli bear case enu estim
mn revenu growth deceler livongo
incur difficulti penetr new commerci aso client expand
new payor market slow new client add stall membership growth
platform first-mov advantag posit
well take share penetr
diabet manag market
adjac hypertens market
expand jumbo employ market
could open increment
address diabet patient
relationship channel partner includ
express script
addit upsid opportun
expans new payor market includ
medicar advantag commerci full-
risk cross-sel exist
instal base product offer
weight manag behavior health
current valuat believ market
alreadi price growth potenti
lead equal-weight rate
success cross sell hyper tension
quarterli earn earn
fortun compani larg aso client
risk achiev price
high concentr revenu five
channel partner one
product
healthplan
could develop offer
eat market opportun
repres bp headwind
step sale market spend
expand larger employ market
initi coverag livongo equal-weight rate pt
livongo found consumer-centr digit health platform
leverag technolog help individu chronic condit better manag
health result improv adher better outcom lower cost
compani model leverag relationship channel partner effici
contract mid larg employ employe base compani uniqu
subscription-bas recur revenu model base per particip per month
pppm fee give high degre visibl growth
livongo primarili focus type diabet affect million million
american account diabet case per center diseas
control estim diabet account livongo revenu
compani expand suit solut address adjac condit
typic impact individu diabet includ hypertens weight manag
behavior health
livongo innov platform integr technolog exist care methodolog
blood glucos finger stick creat new digit consumer-centr experi
combin healthcar technolog data scienc behavior insight help
support behavior chang type patient drive improv clinic outcom
ultim lower cost platform coupl livongo first mover advantag
posit well captur share estim billion diabet market
penetr expect larg greenfield market opportun support
revenu compound-annual-growth-rate potenti upsid compani add larger
client expand new payor market cross-sel new product hypertens
weight management/pre-diabet behavior health diabet client base
see three debat shape market sentiment trade
multipl revenu trajectori durabl growth whether emerg
competit catch livongo gross margin profil
revenu growth function livongo abil tap jumbo employ
market move upmarket would open live livongo
estim million would address type see exhibit sell
jumbo employ could entail execut risk longer sale cycl increas level
sale market invest exist channel partnership health plan
pbm top five partner includ express script hcsc highmark
alreadi access larg employ client help mitig risk
exhibit move upmarket open million address diabet live livongo
livongo opp
move upstream
open
live
tam
assumpt
core focu
livongo
exhibit livongo top channel partner account revenu
competitor back healthplan could gain traction market penetr
see long runway livongo account invest omada
unit choos align livongo exclud
address market calcul popul manag two payor medicar
advantag commerci full-risk even adjust market opportun
billion billion forecast assum livongo manag
address diabet opportun leav ampl room
growth exclud commerci
aso employ employ still directli contract livongo even
health plan/pbm hypertens still earli stage launch
whole person manag set livongo apart establish diabet player
glucomet manufactur like abbott johnson johnson bayer roch
continu glucos monitor compani like could look
partner/alreadi partner compani like googl digit blood glucos
read none provid wrap-around servic coach data analyt help
manag entir type patient
exhibit livongo could convert market opportun current
base disclos enrol
exclud livongo address diabet opportun commerci full risk current partner livongo
total address popul sum due overlap hypertens diabet
cdc censu bureau bureau labor statist kaiser american diabet associ morgan stanley research
near-term gross margin like cap rapid member growth
expand bp long-term acceler new member add well payor
product mix diabet product cost amort month like drive
margin volatil cap gross margin next year
cost absorb mix shift busi model support gross margin
rang long-term
model valuat
model forecast support revenu compound-annual-growth-rate next three year model
revenu million respect
translat y/i revenu growth primarili driven new
commerci aso client add diabet market expect gross margin taper
respect
reflect combin payor mix shift compani expand medicar
commerci full-risk segment character lower margin profil
product mix shift compani ramp hypertens membership non-gaap
basi model livongo break even oper profit net incom
catalyst earn model revenu million y/i
growth includ million driven diabet metric track includ
end member count product payor new client add cross-sel
rate valuat ew pt compani subscription-bas recur revenu
model high sticki client strong secular growth driver industri
first-mov advantag larg under-penetr market provid livongo
long runway growth support premium valuat view said stock
ipo vs
valu livongo ev/revenu basi use high-growth saa compani
high-growth healthcar compani comp livongo revenu growth profil higher
comp group livongo growth vs high-growth saa
high-growth healthcar respect gross margin profil higher
hc comp lower saa peer appli averag ev/revenu
multipl group base case revenu estim
million arriv price
risk move upmarket larger employ could take longer
forecast may requir increment invest revenu
gener five channel partner one discontinu relat
livongo could materi impact sale growth plan
could develop offer eat market
opportun see debat one competit impact realiz diabet
debat one competit impact realiz diabet
debat summari livongo establish market leader diabet digit
health manag sinc incept howev digit health market
still earli inning diabetes-focus start-up exampl includ onduo
omada follow livongo footstep develop similar solut
other work offer area hypertens behavior health see
report incub innov role privat compani healthcar
addit payor yet partner livongo instead
opt develop intern solut other
invest start-up develop similar offer omada health ultim
rais question realiz address market livongo
morgan stanley take consid high sticki associ employ benefit
contract industri standard renew rate first-mov advantag
critic success factor benefit livongo narrow address market
exclud share manag live think livongo diabet
still sizabl billion moreov model forecast suggest livongo
penetr opportun leav ampl runway growth
analysi section focus mainli impact competit realiz
market diabet repres near-term address opportun
exhibit diabet market opportun commerci medicar advantag
note exclud livongo address diabet opportun commerci full risk current partner livongo
livongo first publicly-trad compani within digit health space target
diabet space market earli phase evolut emerg
competitor rang start-up develop similar solut omada health
one drop devic manufactur work develop vari version closed-
loop system tandem beta bionic bigfoot biomed compani
seek chang diabet standard care competitor like
omada health onduo fund strateg investor includ payor
pharma compani sanofi identifi privat competitor
diabet market total invest million five omada
often refer channel check onduo verili sanofi back
ventur primarili focus type diabet stand well-fund
privat compani million capit rais see exhibit
exhibit compani focus address diabet use digit health model
relationship could provid smaller privat compani platform sell
access member healthcar data could make smarter offer notabl
alreadi made strateg invest type diabet platform
omada health januari unitedhealthcar began partner
pilot individu glucos manag program provid continu glucos
monitor cgm devic diabet monitor condit real-tim though
partnership like focus type diabet segment outsid livongo
core market convers suggest compani start
work real time data collect within chronic diseas patient popul
initi infanc focus around understand valu
compani bring end-memb rather tri gain new member
exhibit model livongo penetr near-term address diabet opportun
base disclos enrol
exclud livongo address diabet opportun commerci full risk current partner livongo
total address popul sum due overlap hypertens diabet
cdc censu bureau bureau labor statist kaiser american diabet associ morgan stanley research
much share unit captur direct-to-employ market
livongo revenu estim revenu
carv medicar advantag fully-insur fi market
manag health plan exclud member manag
unitedhealthcar calcul livongo address tam
fi market estim unitedhealthcar manag
live fi live respect
remain market opportun still repres meaning runway growth
adjust unitedhealthcar market share estim livongo
address diabet market opportun million includ million live
commerci aso million live commerci full-risk million live
medicar advantag model livongo end diabet member count
penetr grow member penetr
hypertens still earli stage launch repres anoth
debat sustain near-term revenu growth
debat summari grow revenu y/i estim
key debat amongst investor sustain growth profil
livongo believ tech investor would think revenu deceler model
growth growth steep healthcar investor
like comfort deceler
take last year livongo success sell
increasingli larger employ group said fortun employ still account
custom base think tap jumbo employ remain key
sustain livongo growth profil consid mid-way livongo
ad new diabet client believ come smaller employ
group model assumpt new jumbo employ commerci aso
client add appear reason expand new payor market
cross sell new offer exist custom support growth
improv member churn success would anoth sourc upsid
exhibit build block revenu growth
move upmarket open almost larger member opportun livongo
estim livongo current target market includ employ
employe provid livongo type diabet member opportun
translat million near-term address revenu pool jumbo employ
employe repres rel untap opportun could
translat anoth million individu type diabet estim livongo
penetr employ market client includ
fortun
exhibit move upmarket open million address diabet live livongo
livongo opp
move upstream
open
live
tam
assumpt
core focu
livongo
sign new commerci aso client key drive long-term revenu growth
model ad averag new commerci aso client employe
rang drive revenu growth largest build block
revenu growth impli jumbo employ penetr
diabet member view client add assumpt reason given
compani sign client client first half
catalyst watch press releas new fortun compani larg aso
organ sign livongo
lever growth includ expans new payor market medicar
advantag commerci full risk cross-sel hypertens weight
manag behavior health discuss debat penetr new
payor market full risk would add increment billion
billion revenu opportun respect livongo assum modest adopt
market next three year penetr revenu
contribut overal revenu growth respect
cross sell new offer launch exist member anoth area
focu livongo assum member ramp hypertens drive revenu
growth product still rel new launch
model modest ramp next three year estim cross-sel
diabet base addit bp translat upsid
base case assumpt
churn key lever watch repres upsid model model assum
member churn rate per month go forward churn report
estim everi bp improv churn would result increas
revenu growth respect context histor churn driven
three main factor loss member elig member leav current
employ member inact member classifi non-act longer
paid month activ client contract termin
note model current assum monthli churn rate highlight gold tabl
debat three margin expans opportun
debat summari key debat among investor opportun margin expans
whether livongo gross profit margin expand mid level saa comp
take new member add payor mix product mix expect
drive margin volatil cap gross margin profil next
year compani experienc acceler growth phase on-board
new member longer term busi model support gross margin
rang highlight factor impact margin product categori payor
gross margin face near-term pressur reflect amort glucomet
first month upsid opportun expand year sinc
amort cost glucomet devic recogn cost revenu first
month new member onboard repres gross margin headwind first
two year amplifi rapid pace diabet membership growth two year
assum product refresh exist member hypothet analysi
suggest commerci aso diabet gross margin expand year
year see exhibit context cost good sold associ
diabet product includ health coach cost test strip cost glucomet
amort month cellular data
exhibit hypothet analysi diabet gross margin assum product upgrad
year usag
total revenu assum pppm
note analysi assum product refresh word diabet member issu new glucomet year
mix shift commerci aso medicar commerci risk popul
repres headwind overal diabet gross margin
medicar full-risk offer sold lower price point model
commerci risk versu exist aso custom
lower gross profit margin profil model estim commerci aso diabet
gross margin bp medicar gross margin
bp full-risk gross margin
bundl diabet new offer hypertens come price
concess model assum member buy diabet hypertens
bundl commerci aso diabet member increas
receiv price discount lead lower revenu pppm gross margin
exhibit payor product mix translat margin headwind
livongo expens full cost blood pressur meter first month new
member onboard translat neg gross margin new hypertens
member first quarter revers month two devic fulli expens
gross margin stabil exhibit therefor quarter largest
sequenti increas enrol hypertens member typic
strongest season commerci enrol growth experi largest
sequenti declin hypertens gross margin
exhibit hypertens gross margin improv first quarter
total revenu assum pppm
note estim run-rat variabl cog hypertens member per month appli pppm start
impli hypertens gross margin go toward member beyond first month
quarterli variat hypertens gross margin primarili driven first
month expens increas prior livongo plan introduc
new expens blood pressur monitor octob averag
hypertens revenu pppm steadili increas new
client charg full price solut exist custom given
discount adopt solut
exhibit quarterli gross margin fluctuat driven new product launch price increas season membership growth
put togeth
net-net factor move part discuss estim overal margin
stabil consid move part diabet
hypertens payor product mix like weigh margin trend two
product gross margin contract augment
growth lower margin behavior health weight manag offer expect
quarterli variat driven combin onboard new lower-margin
diabet member introduct new hypertens product new price
hypertens member separ analysi diabet hypertens
weight manag behavior health product account revenu
margin profil lower core offer estim gross margin see
upsid opportun driven diabet member keep glucomet
month cost glucomet devic fulli amort
exhibit estim overal gm declin next year livongo rapidli add new diabet member lower-margin payor
segment new hypertens member
deep dive model assumpt
model livongo revenu million million million
respect impli growth three key
driver top-line growth built model includ
averag pppm per-particip per-month price base product type
diabet vs hypertens payor type commerci aso vs medicar vs full-
new member add function new client sign recruit popul
diabet
monthli member churn rate loss member
exhibit price gross margin assumpt product
total
note revenu bundl product disaggreg correspond product line diabet hypertens diabet bundl diabet hypertens near-term margin calcul first
two year target margin calcul year hypertens near-term margin calcul first quarter target margin calcul second quarter beyond
diabet hypertens product price pppm basi see exhibit
employ payor client pay monthli subscript fee member
activ engag product price vari payor commerci aso
highest follow medicar advantag commerci full-risk product
type diabet highest follow hypertens employ choos
offer member one product assum bundl price discount
weight manag behavior product price base
mileston membership fee manag plan convert pppm
basi futur
manag live function exist custom base new quarterli add
preval diabet among employe popul model assum
member adopt commerci aso employ assum
address popul adopt livongo offer within month
within month context livongo best-in-class employ reach
penetr level among employe popul current overal averag
adopt
note client implement ramp vari base type size complex
payor employ accordingli factor model full-risk client
medicar advantag member take longer ramp reach within
month initi contract implement
exhibit recruit popul vari product payor market
note input display base case assumpt
monthli member churn rate swing factor model assum monthli
member churn base bear case monthli member churn rate in-
line histor rate experienc bull case histor
churn come loss elig member leav current employ
come laps member longer activ solut
come client contract termin estim improv churn rate
bp result increas revenu growth rate
includ cog cost devic diabet glucomet amort
month hypertens devic fulli expens month
member join cost test strip provid member free salari paid
health coach monthli data/cellular plan keep devic network
exhibit summari gross profit margin refer debat three
margin expans opportun in-depth discuss
exhibit annual gross profit margin product payor market
hypertens
note calcul revenu cog gross profit annual basi better compar diabet hypertens hypertens month-on neg gross margin due expens devic
cost follow gross margin month-two onward
line item consist tech engin clinic data scienc model non-gaap
 percentag sale declin
 expens includ financ legal hr oper regulatori suppli chain
manag compani plan move function higher cost
san francisco lower cost could includ off-shore locat model non-gaap
 percentag sale declin
sale market expens
livongo incur fix variabl sale market expens fix expens
includ market team account manag busi develop variabl
expens includ variabl commiss fee paid partner member market
expens sale rep salari assum growth fix year
variabl expens main driver cost includ
commissions/fe commiss paid channel partner
bring new client perform final sale assum partner fee
revenu
sale commiss sale commiss paid intern sale forc base
first year revenu new contract sign assum sale commiss
revenu respect time
livongo could chang commiss structur base percentag
total contract valu tcv in-lin softwar compani
typic compens rep
enrol market cost market toward end-memb includ
cost market letter email direct mail assum expens
revenu respect
upcom account chang
sinc major compani revenu bill monthli recogn
subscription-basi expect littl effect revenu main effect
capit sale commiss expens lead deferr
recognit sale expens increas profit near-term
work capit area improv manag would like restructur
contract collect receiv sooner push payabl
compani report work capit grow model
model livongo cash flow neg model
cash burn compani steeper oper cash loss introduc
capit softwar expens estim cash burn oper
cash flow improv capit softwar cost increas
capit alloc focu intern oper livongo put forth specif
capit alloc strategi compani oper without materi debt
free cash return sharehold model horizon expect reinvest
busi main use cash possibl continu tuck-in deal
section discuss valuat framework compar compani analysi
outlin revenu growth scenario bull base bear case
consid livongo revenu growth profil expect compani
turn profit view ev/sal appropri
methodolog valu livongo compani pure-play public
compani compar consid differ comp set exhibit overview
compar group exhibit comp tabl
exhibit summari comp group use valuat
base case price target base ev/revenu appli base case
revenu million repres upsid consid livongo uniqu growth
profil low penetr address market opportun sticki custom
base gross margin profil includ high-growth saa compani high-growth
healthcar compani base case comp group trade averag
paycom workday payloc pluralsight guardant shockwav twist
bioscienc comp group estim accord consensu estim
grow top-line averag forecast growth rate livongo
averag gross margin profil comp group rang
livongo line compani long term target
bull case valuat base ev/revenu appli bull case revenu
million repres upsid bull case assum
livongo annual new address member acceler million
million respect monthli member churn rate stay
current rate look recent high growth ipo compar includ
softwar name zoom slack healthcar name guardant shockwav
twist bull comp group top-line growth profil livongo comp
averag vs livongo bull case gross margin profil similar comp
averag vs livongo averag ev/revenu multipl
group
bear case valuat base ev/revenu appli bear case revenu
million repres downsid bear case assum
livongo take longer penetr jumbo employ segment new client add
deceler current level monthli member churn rate increas
in-lin assum base case compar look
compani meaning lower top-line growth rate includ tradit
healthcar compani inovalon softwar name pluralsight
compani averag expect grow top-line vs livongo bear
case gross margin profil vs livongo averag
ev/revenu multipl group
exhibit bull/base/bear valuat impli return
impli return current price
valuat methodolog risk associ recommend rate price target referenc report pleas contact client support follow us/canada hong kong latin america london singapor sydney
tokyo altern may contact invest repres morgan stanley research broadway attent research manag new york ny usa
four key assumpt vari bull/base/bear scenario annual number
new recruit diabet commerci aso member enrol penetr achiev new client
within month price discount diabet hypertens bundl sale monthli member
churn rate exhibit summari revenu growth scenario well key assumpt
exhibit revenu growth bull/base/bear case along key assumpt
base case expect livongo achiev revenu growth
respect assum client ad translat million new
address diabet respect addit assum client sign
reach member penetr month client sign reach member
penetr month assum steadi ramp new member commerci full-risk market
diabet continu cross-sel hypertens product diabet base final assum monthli
member churn rate
bull case model livongo client ramp commerci aso market continu acceler
member churn decreas monthli translat revenu growth respect
addit assum compani success acceler member onboard process client
sign reach member penetr month increas base case
client sign reach member penetr month increas
base case final assum bundl product diabet hypertens receiv
bear case assum livongo new client add commerci aso market deceler translat
revenu growth slow respect addit assum compani
onboard process cap member penetr final assum steeper discount
move upmarket come sale risk
livongo look penetr larger employ market may requir increment
invest beyond forecast sell jumbo employ could entail
execut risk longer sale cycl increas level sale market
invest comfort assumpt given livongo exist channel
partnership health plan pbm alreadi access larg employ client
high relianc channel partner
highmark repres compani revenu
overreli channel partner repres signific risk revenu one
discontinu work compani comfort livongo
unlik lose channel partner given mutual benefici relationship channel
partner receiv commiss livongo better posit amongst
member offer livongo servic
competit plan could reduc market
payor relationship could provid smaller privat compani platform sell
access member healthcar data could make smarter offer humana
alreadi made strateg invest type diabet platform omada
discuss earli initi space
account competit size address market larg health plan
look solidifi presenc space could neg impact
million
compani data morgan stanley research
million except pppm
revenu product
revenu payor
compani data morgan stanley research
million
compani data morgan stanley research
million
chang work capit
total chang work capit
flow oper
flow invest
flow financ
effect fx
chang
compani data morgan stanley research
livongo uniqu consumer-fac digit health platform address peopl
compani four main product includ diabet hypertens weight
manag behavior health major compani revenu come
diabet product
exhibit livongo product span diabet hypertens weight manag behavior health
livongo diabet target toward member type type diabet
member provid cellular-connect smart blood glucos meter
unlimit blood glucos test strip finger prick meter provid
person health nudg base member health profil blood
glucos test data help member take step toward improv health
member access health coach answer question
provid support phone well proactiv reach member
whose blood glucos test return abnorm read data sync
across sever differ interfac mobil web email allow member
interact whatev devic prefer also allow data share
famili member physician help provid encourag support
livongo hypertens launch august come blood
pressur monitor cuff transmit data mobil app similar
diabet product member receiv person nudg help manag
blood pressur access health coach
livongo prediabet weight manag acquir via retrofit april
target toward member risk develop diabet
overweight member provid smart cellular-en scale
connect mobil devic livongo app provid member
access person coach dietician physiologist well group
exercis class on-line commun health educ content help
member develop better eat exercis habit
livongo behavior health acquir via mystrength februari
provid member app-bas approach improv mental health
accept commit therapi posit psycholog mind
motiv interview help member improv mental state build
resili manag stress improv mood
exhibit list livongo main privat competitor diabet hypertens
behavior health market would specif highlight onduo verili sanofi
back ventur primarili focus type diabet well-fund privat
compani million capit rais omada health compani
list strateg investor includ
note list meant exhaust includ compani livongo consid competitor includ feedback due dilig compani product client consid
exhibit season manag team experi run publicly-trad compani
